Zenith Drugs
Zenith Drugs Info
Details about the Zenith Drugs IPO. Opening Date of Zenith Drugs is 19 Feb 24 and Closing Date is 22 Feb 24 . Face Value of Each share of Zenith Drugs is ₹10 per share. Price band of Zenith Drugs is ₹75 to ₹79. The Lot size of Zenith Drugs is 1,600 shares. Total issue size of Zenith Drugs IPO is ₹40.68 cr. Fresh Issue of Zenith Drugs IPO is 40.68 cr. This is a Book Building IPO. Expected to list on NSE SME. Share Holding Pre Issue of Zenith Drugs is 12,000,000. Share Holding Post Issue of Zenith Drugs is 17,148,800.
Business Summary
Zenith Drugs is a pharmaceutical manufacturing and trading company based out from Indore.
Currently, Company is having FDA approval of more than 600 Products from Food & Drugs Administration. Out of 600 Products, 325 products are being Manufactured Regularly.
Company is in process to establish a new factory at its land located at Village Muradpura, Depalpur, Indore
Zenith Drugs IPO Details
| Open Date | 19 Feb 24 |
|---|---|
| Close Date | 22 Feb 24 |
| Face Value | ₹10 per shares |
| Price Band | ₹75 - ₹79 |
| Lot Size | 1,600 Shares |
| Total issue Size | 5,148,800 Shares ₹40.68 cr |
| Fresh Issue | 5,148,800 Shares ₹40.68 cr |
| Issue Type | Book Building |
| Listing At | NSE SME |
| Share Holding Pre Issue | 12,000,000 |
| Share Holding Post Issue | 17,148,800 |
| Market Maker | Gretex Share Broking |
| Market Maker Portion | 852,800 Shares |
| RHP , DHRP | View RHP, View DRHP |
Zenith Drugs IPO Timeline
The Zenith Drugs Initial Public Offering (IPO) is set to open on 19 Feb 24 and will end its subscription phase on 22 Feb 24. You can check your allotment status for Zenith Drugs on 23 Feb 24. The refund process for your funds will start promptly on 26 Feb 24. Zenith Drugs IPO credit of shares will be on 26 Feb 24. The listing date for Zenith Drugs is on 27 Feb 24.
Open Date
Close Date
Basis Of Allotment
Initialization of Refund
Credit of Share
Listing Date
Zenith Drugs IPO Reservation
The Zenith Drugs IPO reserves shares for different investor categories. Approximately Not more than 50% of the Net Issue will be available for QIB, Not less than 15% of the Net Issue will be available for NII, Not less than 35% of the Net Issue will be available for Retail,
852,800 Shares will be reserved for subscription by Gretex Share Broking
| Investor Category | Shares Offered |
|---|---|
| QIB | Not more than 50% of the Net Issue |
| NII | Not less than 15% of the Net Issue |
| Retail | Not less than 35% of the Net Issue |
Zenith Drugs IPO Lot Size
Bids can be made for minimum of 1600 shares and in multiple of 1600 equity shares thereafter
| Application | Lot | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,600 | 126,400 |
| Retail (Max) | 1 | 1,600 | 126,400 |
| HNI (Min) | 2 | 3,200 | 252,800 |
Zenith Drugs IPO Promoters Holding
Promoters holding details for Zenith Drugs in the current issue is as follows: The share holding of promoters before the issue stands at 100%, and after the issue, it has been adjusted to 69.98%.
Promoters of Zenith Drugs are Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni, Mr. Ajay Singh Dassundi,
| Share Holding Pre Issue | 100% |
|---|---|
| Share Holding Post Issue | 69.98% |
Zenith Drugs Financial Information
Financial performance details for Zenith Drugs over the years are as follows: The table below presents key financial indicators, including Assets, Revenue, and Profit After Tax (PAT).
| Period | 30 Sept 23 | 31 Mar 23 | 31 Mar 22 |
|---|---|---|---|
| Assets | 11,249.04 | 9,793.83 | 6,858.47 |
| Revenue | 6,948.43 | 11,569.65 | 9,266.63 |
| Profit After Tax | 539.38 | 515.29 | 312.86 |
Zenith Drugs IPO Key Performance Indicator
Key Performance Indicators (KPIs) for Zenith Drugs are outlined below. Monitoring these KPIs provides insights into the company's operational and strategic performance. The table presents various performance indicators along with their corresponding values.
| KPI | Value |
|---|---|
| P/E (x) | 18.4 |
| ROCE | 37.29% |
| ROE | 35.13% |
| RoNW | 29.88% |
| EPS (Rs) | 4.29 |
Object of the Issue
- • Purchase of Machinery & Equipments for Setting up New Unit
- • Existing Manufacturing Block Upgradation
- • Working Capital Requirements
- • General Corporate Purposes
Contact Details for Zenith Drugs
Phone
Office
K. No. 72/5, Village Muradpura, NA Depalpur, Indore-453001, Madhya Pradesh, India.
Registrar Details for Zenith Drugs
Bigshare Services Pvt Ltd
Phone
Office
S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai – 400093 MH, India.
Lead Manager
- • Gretex Corporate Services Limited